MORETTO, ROBERTO Statistiche
MORETTO, ROBERTO
DIP. DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA - disattivato (attivo dal 19/09/2012 al 31/12/2019)
Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment
2026-01-01 Moretto, Roberto; Studiale, Vittorio; Hyun, Seung Won; Vetere, Guglielmo; Islam, Farahnaz; Carullo, Martina; Conca, Veronica; Lo, Christine; Neems, Daniel; Boulos, Hala; Desantis, Dana F; Germani, Marco Maria; Taravella, Ada; Landi, Matteo; Ghelardi, Filippo; De Grandis, Maria Caterina; Murgioni, Sabina; Abran, John; Sasser, Kate; Pietrantonio, Filippo; Chiou, Victoria L; Sangli, Chithra; Nimeiri, Halla; Cremolini, Chiara
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO
2026-01-01 Ciracì, P; Germani, M M; Pietrantonio, F; Manca, P; Lonardi, S; Busico, A; Bergamo, F; Burgio, V; Mannavola, F; Di Donato, S; Fenocchio, E; Palermo, F; Capone, I; De Grandis, M C; Pella, N; Scartozzi, M; Antonuzzo, L; Passardi, A; Claravezza, M; Salvatore, L; Tamberi, S; Randon, G; Conca, E; Conca, V; Antoniotti, C; Moretto, R; Masi, G; Boni, L; Rossini, D; Cremolini, C
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study
2026-01-01 Conca, Veronica; Rossini, Daniele; Antoniotti, Carlotta; Lonardi, Sara; Pietrantonio, Filippo; Moretto, Roberto; Antonuzzo, Lorenzo; Randon, Giovanni; Lavacchi, Daniele; Pozzo, Carmelo; Marmorino, Federica; Bergamo, Francesca; Tamburini, Emiliano; Passardi, Alessandro; Fazio, Roberta; Murgioni, Sabina; Borelli, Beatrice; Buonadonna, Angela; Germani, Marco Maria; Formica, Vincenzo; Carullo, Martina; Bordonaro, Roberto; Aprile, Giuseppe; Zaniboni, Alberto; Masi, Gianluca; Boni, Luca; Cremolini, Chiara
Total neoadjuvant treatment, non-operative management and radiotherapy-free strategies: New approaches for the management of proficient mismatch repair/microsatellite stable locally advanced rectal cancer. A narrative review and evidence-based algorithm
2025-01-01 Moretto, R.; Boccaccio, C.; Landi, M.; Masi, G.; Cremolini, C.
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study
2023-01-01 Moretto, Roberto; Rossini, Daniele; Catteau, Aurélie; Antoniotti, Carlotta; Giordano, Mirella; Boccaccino, Alessandra; Ugolini, Clara; Proietti, Agnese; Conca, Veronica; Kassambara, Alboukadel; Pietrantonio, Filippo; Salvatore, Lisa; Lonardi, Sara; Tamberi, Stefano; Tamburini, Emiliano; Poma, Anello Marcello; Fieschi, Jacques; Fontanini, Gabriella; Masi, Gianluca; Galon, Jérôme; Cremolini, Chiara
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy
2023-01-01 Moretto, Roberto; Germani, Marco Maria; Ros, Javier; Daniel, Francesca; Ghelardi, Filippo; Vetere, Guglielmo; Giordano, Mirella; Toledo, Rodrigo De Almeida; Bergamo, Francesca; Randon, Giovanni; Elez, Elena; Lonardi, Sara; Pietrantonio, Filippo; Vignali, Paola; Rossini, Daniele; Matito, Judit; Ugolini, Clara; Fontanini, Gabriella; Masi, Gianluca; Cremolini, Chiara
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials
2023-01-01 Rossini, Daniele; Boccaccino, Alessandra; Carullo, Martina; Antoniotti, Carlotta; Dima, Giovanni; Ciracì, Paolo; Marmorino, Federica; Moretto, Roberto; Masi, Gianluca; Cremolini, Chiara
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients
2023-01-01 Borelli, Beatrice; Crucitta, Stefania; Boccaccino, Alessandra; Antista, Maria; Antoniotti, Carlotta; Marmorino, Federica; Rossini, Daniele; Conca, Veronica; Germani, Marco Maria; Provenzano, Leonardo; Spagnoletti, Andrea; Leone, Alberto Giovanni; Cucchiara, Federico; Pietrantonio, Filippo; Del Re, Marzia; Danesi, Romano; Masi, Gianluca; Cremolini, Chiara; Moretto, Roberto
Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence
2023-01-01 Urbani, Lucio; Roffi, Nicolò; Moretto, Roberto; Signori, Stefano; Balestri, Riccardo; Rossi, Elisabetta; Colombatto, Piero; Licitra, Gabriella; Leoni, Chiara; Martinelli, Rita; Meiattini, Daniele Anacleto; Bonistalli, Emidio; Borelli, Beatrice; Antoniotti, Carlotta; Masi, Gianluca; Rossini, Daniele; Boraschi, Piero; Donati, Francescamaria; Della Pina, Maria Clotilde; Lunardi, Alessandro; Daviddi, Francesco; Crocetti, Laura; Tonerini, Michele; Gigoni, Roberto; Quilici, Francesca; Gaeta, Raffaele; Turco, Francesca; Paolicchi, Adriana; Volterrani, Duccio; Nardini, Vincenzo; Buccianti, Piero; Forfori, Francesco; Puccini, Marco; Cremolini, Chiara
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
2022-01-01 Boccaccino, A; Borelli, B; Intini, R; Antista, M; Bensi, M; Rossini, D; Passardi, A; Tamberi, S; Giampieri, R; Antonuzzo, L; Noto, L; Roviello, G; Zichi, C; Salati, M; Puccini, A; Noto, C; Parisi, A; Rihawi, K; Persano, M; Crespi, V; Libertini, M; Giordano, M; Moretto, R; Lonardi, S; Cremolini, C
The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features
2022-01-01 Germani, M. M.; Borelli, B.; Boraschi, P.; Antoniotti, C.; Ugolini, C.; Urbani, L.; Morelli, L.; Fontanini, G.; Masi, G.; Cremolini, C.; Moretto, R.
Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection
2022-01-01 Urbani, Lucio; Roffi, Nicolò; Signori, Stefano; Balestri, Riccardo; Colombatto, Piero; Licitra, Gabriella; Leoni, Chiara; Meiattini, Daniele; Moretto, Roberto; Cremolini, Chiara; Masi, Gianluca; Boraschi, Piero; Quilici, Francesca; Buccianti, Piero; Puccini, Marco
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
2021-01-01 Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietrantonio, Filippo; Tomasello, Gianluca; Passardi, Alessandro; Tamburini, Emiliano; Santini, Daniele; Aprile, Giuseppe; Masi, Gianluca; Falcone, Alfredo; Lenz, Heinz-Josef; Korn, Michael; Cremolini, Chiara
The landscape of alterations in DNA damage response pathways in colorectal cancer
2021-01-01 Arai, H.; Elliott, A.; Xiu, J.; Wang, J.; Battaglin, F.; Kawanishi, N.; Soni, S.; Zhang, W.; Millstein, J.; Sohal, D.; Goldberg, R. M.; Hall, M. J.; Scott, A. J.; Khushman, M.; Hwang, J. J.; Lou, E.; Weinberg, B. A.; Marshall, J. L.; Lockhart, A. C.; Stafford, P.; Zhang, J.; Moretto, R.; Cremolini, C.; Korn, W. M.; Lenz, H. -J.
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
2020-01-01 Antoniotti, C.; Borelli, B.; Rossini, D.; Pietrantonio, F.; Morano, F.; Salvatore, L.; Lonardi, S.; Marmorino, F.; Tamberi, S.; Corallo, S.; Tortora, G.; Bergamo, F.; Brunella, D. S.; Boccaccino, A.; Grassi, E.; Racca, P.; Tamburini, E.; Aprile, G.; Moretto, R.; Boni, L.; Falcone, A.; Cremolini, C.
Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
2020-01-01 Moretto, R.; Falcone, A.; Cremolini, C.
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest
2020-01-01 Moretto, R.; Rossini, D.; Zucchelli, G.; Lonardi, S.; Bergamo, F.; Santini, D.; Cupini, S.; Tomasello, G.; Caponnetto, S.; Zaniboni, A.; Antoniotti, C.; Pietrantonio, F.; Buonadonna, A.; Marmorino, F.; Bordonaro, R.; Fea, E.; Tamburini, E.; Boccaccino, A.; Grande, R.; Aprile, G.; Falcone, A.; Cremolini, C.
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells
2020-01-01 Orlandi, P.; Gentile, D.; Banchi, M.; Cucchiara, F.; Di Desidero, T.; Cremolini, C.; Moretto, R.; Falcone, A.; Bocci, G.
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials
2020-01-01 Moretto, R.; Corallo, S.; Belfiore, A.; Rossini, D.; Boccaccino, A.; Lonardi, S.; Centonze, G.; Morano, F.; Germani, M. M.; Loupakis, F.; Morelli, L.; Urbani, L.; Brich, S.; Marmorino, F.; Prisciandaro, M.; Aprile, G.; Fassan, M.; Cillo, U.; Cattaneo, L.; Fontanini, G.; De Braud, F.; Falcone, A.; Milione, M.; Pietrantonio, F.; Cremolini, C.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO
2020-01-01 Rossini, D.; Lonardi, S.; Antoniotti, C.; Santini, D.; Tomasello, G.; Ermacora, P.; Germani, M. M.; Bergamo, F.; Ricci, V.; Caponnetto, S.; Moretto, R.; Zaniboni, A.; Pietrantonio, F.; Buonadonna, A.; Ritorto, G.; Masi, G.; Latiano, T. P.; Rapisardi, S.; Falcone, A.; Cremolini, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Circulating tumor DNA dynamics in patients with liver-limited metastatic colorectal cancer resected after first-line systemic treatment | 1-gen-2026 | Moretto, Roberto; Studiale, Vittorio; Hyun, Seung Won; Vetere, Guglielmo; Islam, Farahnaz; Carullo, Martina; Conca, Veronica; Lo, Christine; Neems, Daniel; Boulos, Hala; Desantis, Dana F; Germani, Marco Maria; Taravella, Ada; Landi, Matteo; Ghelardi, Filippo; De Grandis, Maria Caterina; Murgioni, Sabina; Abran, John; Sasser, Kate; Pietrantonio, Filippo; Chiou, Victoria L; Sangli, Chithra; Nimeiri, Halla; Cremolini, Chiara | |
| Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO | 1-gen-2026 | Ciracì, P; Germani, M M; Pietrantonio, F; Manca, P; Lonardi, S; Busico, A; Bergamo, F; Burgio, V; Mannavola, F; Di Donato, S; Fenocchio, E; Palermo, F; Capone, I; De Grandis, M C; Pella, N; Scartozzi, M; Antonuzzo, L; Passardi, A; Claravezza, M; Salvatore, L; Tamberi, S; Randon, G; Conca, E; Conca, V; Antoniotti, C; Moretto, R; Masi, G; Boni, L; Rossini, D; Cremolini, C | |
| Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study | 1-gen-2026 | Conca, Veronica; Rossini, Daniele; Antoniotti, Carlotta; Lonardi, Sara; Pietrantonio, Filippo; Moretto, Roberto; Antonuzzo, Lorenzo; Randon, Giovanni; Lavacchi, Daniele; Pozzo, Carmelo; Marmorino, Federica; Bergamo, Francesca; Tamburini, Emiliano; Passardi, Alessandro; Fazio, Roberta; Murgioni, Sabina; Borelli, Beatrice; Buonadonna, Angela; Germani, Marco Maria; Formica, Vincenzo; Carullo, Martina; Bordonaro, Roberto; Aprile, Giuseppe; Zaniboni, Alberto; Masi, Gianluca; Boni, Luca; Cremolini, Chiara | |
| Total neoadjuvant treatment, non-operative management and radiotherapy-free strategies: New approaches for the management of proficient mismatch repair/microsatellite stable locally advanced rectal cancer. A narrative review and evidence-based algorithm | 1-gen-2025 | Moretto, R.; Boccaccio, C.; Landi, M.; Masi, G.; Cremolini, C. | |
| Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study | 1-gen-2023 | Moretto, Roberto; Rossini, Daniele; Catteau, Aurélie; Antoniotti, Carlotta; Giordano, Mirella; Boccaccino, Alessandra; Ugolini, Clara; Proietti, Agnese; Conca, Veronica; Kassambara, Alboukadel; Pietrantonio, Filippo; Salvatore, Lisa; Lonardi, Sara; Tamberi, Stefano; Tamburini, Emiliano; Poma, Anello Marcello; Fieschi, Jacques; Fontanini, Gabriella; Masi, Gianluca; Galon, Jérôme; Cremolini, Chiara | |
| Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy | 1-gen-2023 | Moretto, Roberto; Germani, Marco Maria; Ros, Javier; Daniel, Francesca; Ghelardi, Filippo; Vetere, Guglielmo; Giordano, Mirella; Toledo, Rodrigo De Almeida; Bergamo, Francesca; Randon, Giovanni; Elez, Elena; Lonardi, Sara; Pietrantonio, Filippo; Vignali, Paola; Rossini, Daniele; Matito, Judit; Ugolini, Clara; Fontanini, Gabriella; Masi, Gianluca; Cremolini, Chiara | |
| Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials | 1-gen-2023 | Rossini, Daniele; Boccaccino, Alessandra; Carullo, Martina; Antoniotti, Carlotta; Dima, Giovanni; Ciracì, Paolo; Marmorino, Federica; Moretto, Roberto; Masi, Gianluca; Cremolini, Chiara | |
| TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients | 1-gen-2023 | Borelli, Beatrice; Crucitta, Stefania; Boccaccino, Alessandra; Antista, Maria; Antoniotti, Carlotta; Marmorino, Federica; Rossini, Daniele; Conca, Veronica; Germani, Marco Maria; Provenzano, Leonardo; Spagnoletti, Andrea; Leone, Alberto Giovanni; Cucchiara, Federico; Pietrantonio, Filippo; Del Re, Marzia; Danesi, Romano; Masi, Gianluca; Cremolini, Chiara; Moretto, Roberto | |
| Vessel-Guided Mesohepatectomy for Liver Partition and Staged Major Parenchyma-Sparing Hepatectomies with Super-Selective Portal Vein Embolization or Enhanced ALPPS to Achieve R0 Resection for Colorectal Liver Metastases at the Hepatocaval Confluence | 1-gen-2023 | Urbani, Lucio; Roffi, Nicolò; Moretto, Roberto; Signori, Stefano; Balestri, Riccardo; Rossi, Elisabetta; Colombatto, Piero; Licitra, Gabriella; Leoni, Chiara; Martinelli, Rita; Meiattini, Daniele Anacleto; Bonistalli, Emidio; Borelli, Beatrice; Antoniotti, Carlotta; Masi, Gianluca; Rossini, Daniele; Boraschi, Piero; Donati, Francescamaria; Della Pina, Maria Clotilde; Lunardi, Alessandro; Daviddi, Francesco; Crocetti, Laura; Tonerini, Michele; Gigoni, Roberto; Quilici, Francesca; Gaeta, Raffaele; Turco, Francesca; Paolicchi, Adriana; Volterrani, Duccio; Nardini, Vincenzo; Buccianti, Piero; Forfori, Francesco; Puccini, Marco; Cremolini, Chiara | |
| Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience | 1-gen-2022 | Boccaccino, A; Borelli, B; Intini, R; Antista, M; Bensi, M; Rossini, D; Passardi, A; Tamberi, S; Giampieri, R; Antonuzzo, L; Noto, L; Roviello, G; Zichi, C; Salati, M; Puccini, A; Noto, C; Parisi, A; Rihawi, K; Persano, M; Crespi, V; Libertini, M; Giordano, M; Moretto, R; Lonardi, S; Cremolini, C | |
| The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features | 1-gen-2022 | Germani, M. M.; Borelli, B.; Boraschi, P.; Antoniotti, C.; Ugolini, C.; Urbani, L.; Morelli, L.; Fontanini, G.; Masi, G.; Cremolini, C.; Moretto, R. | |
| Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence: a strategy to achieve R0 liver-sparing resection | 1-gen-2022 | Urbani, Lucio; Roffi, Nicolò; Signori, Stefano; Balestri, Riccardo; Colombatto, Piero; Licitra, Gabriella; Leoni, Chiara; Meiattini, Daniele; Moretto, Roberto; Cremolini, Chiara; Masi, Gianluca; Boraschi, Piero; Quilici, Francesca; Buccianti, Piero; Puccini, Marco | |
| Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications | 1-gen-2021 | Moretto, Roberto; Elliott, Andrew; Zhang, Jian; Arai, Hiroyuki; Germani, Marco Maria; Conca, Veronica; Xiu, Joanne; Stafford, Phillip; Oberley, Matthew; Abraham, Jim; Spetzler, David; Rossini, Daniele; Antoniotti, Carlotta; Marshall, John; Shields, Anthony; Lopes, Gilberto; Lonardi, Sara; Pietrantonio, Filippo; Tomasello, Gianluca; Passardi, Alessandro; Tamburini, Emiliano; Santini, Daniele; Aprile, Giuseppe; Masi, Gianluca; Falcone, Alfredo; Lenz, Heinz-Josef; Korn, Michael; Cremolini, Chiara | |
| The landscape of alterations in DNA damage response pathways in colorectal cancer | 1-gen-2021 | Arai, H.; Elliott, A.; Xiu, J.; Wang, J.; Battaglin, F.; Kawanishi, N.; Soni, S.; Zhang, W.; Millstein, J.; Sohal, D.; Goldberg, R. M.; Hall, M. J.; Scott, A. J.; Khushman, M.; Hwang, J. J.; Lou, E.; Weinberg, B. A.; Marshall, J. L.; Lockhart, A. C.; Stafford, P.; Zhang, J.; Moretto, R.; Cremolini, C.; Korn, W. M.; Lenz, H. -J. | |
| AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer | 1-gen-2020 | Antoniotti, C.; Borelli, B.; Rossini, D.; Pietrantonio, F.; Morano, F.; Salvatore, L.; Lonardi, S.; Marmorino, F.; Tamberi, S.; Corallo, S.; Tortora, G.; Bergamo, F.; Brunella, D. S.; Boccaccino, A.; Grassi, E.; Racca, P.; Tamburini, E.; Aprile, G.; Moretto, R.; Boni, L.; Falcone, A.; Cremolini, C. | |
| Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer | 1-gen-2020 | Moretto, R.; Falcone, A.; Cremolini, C. | |
| Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest | 1-gen-2020 | Moretto, R.; Rossini, D.; Zucchelli, G.; Lonardi, S.; Bergamo, F.; Santini, D.; Cupini, S.; Tomasello, G.; Caponnetto, S.; Zaniboni, A.; Antoniotti, C.; Pietrantonio, F.; Buonadonna, A.; Marmorino, F.; Bordonaro, R.; Fea, E.; Tamburini, E.; Boccaccino, A.; Grande, R.; Aprile, G.; Falcone, A.; Cremolini, C. | |
| Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells | 1-gen-2020 | Orlandi, P.; Gentile, D.; Banchi, M.; Cucchiara, F.; Di Desidero, T.; Cremolini, C.; Moretto, R.; Falcone, A.; Bocci, G. | |
| Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials | 1-gen-2020 | Moretto, R.; Corallo, S.; Belfiore, A.; Rossini, D.; Boccaccino, A.; Lonardi, S.; Centonze, G.; Morano, F.; Germani, M. M.; Loupakis, F.; Morelli, L.; Urbani, L.; Brich, S.; Marmorino, F.; Prisciandaro, M.; Aprile, G.; Fassan, M.; Cillo, U.; Cattaneo, L.; Fontanini, G.; De Braud, F.; Falcone, A.; Milione, M.; Pietrantonio, F.; Cremolini, C. | |
| Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO | 1-gen-2020 | Rossini, D.; Lonardi, S.; Antoniotti, C.; Santini, D.; Tomasello, G.; Ermacora, P.; Germani, M. M.; Bergamo, F.; Ricci, V.; Caponnetto, S.; Moretto, R.; Zaniboni, A.; Pietrantonio, F.; Buonadonna, A.; Ritorto, G.; Masi, G.; Latiano, T. P.; Rapisardi, S.; Falcone, A.; Cremolini, C. |